Spinal Tap: Congress Investigates Medtronic
6 CommentsBy Ed Silverman // June 22nd, 2011 // 6:43 am
• Pharma Blog » Archives
Chuck Grassley
The FDA Criteria For Going After Pharma Executives
21 CommentsBy Ed Silverman // February 8th, 2011 // 8:08 am
The Feds Are Investigating How Many Fraud Cases?
5 CommentsBy Ed Silverman // January 28th, 2011 // 8:20 am
Senators Reintroduce Pay-To-Delay Legislation
4 CommentsBy Ed Silverman // January 26th, 2011 // 12:16 pm
Should Whistleblower Payments Have A Cap?
29 CommentsBy Ed Silverman // January 25th, 2011 // 9:21 am
Stanford, Taxpayer-Funded Research & Disclosures
4 CommentsBy Ed Silverman // January 13th, 2011 // 9:26 am
GAO Denies Problems With Report On FDA’s OCI
1 CommentBy Ed Silverman // December 6th, 2010 // 2:01 pm
Who Was The Mole? GAO Probes Its Own FDA Report
Make a commentBy Ed Silverman // November 30th, 2010 // 10:27 am
What Mistress? The FDA’s Top Cop Is Retiring
10 CommentsBy Ed Silverman // November 23rd, 2010 // 12:18 pm
States Refusing To Give Medicaid Data To Grassley
11 CommentsBy Ed Silverman // November 18th, 2010 // 12:04 pm